Virpax Pharmaceuticals | DEF 14A: Definitive information statements
Virpax Pharmaceuticals | ARS: Annual Report to Security Holders
Virpax Pharmaceuticals | SC 13G: Statement of acquisition of beneficial ownership by individuals-Mitchell P. Kopin(4.99%),Daniel B. Asher(4.99%), etc.
Virpax Pharmaceuticals | 8-K: Current report
Virpax Pharmaceuticals | 424B4: Prospectus
Virpax Pharmaceuticals | EFFECT: Others
Virpax Pharmaceuticals | CORRESP: CORRESP
Virpax Pharmaceuticals | S-1/A: General form for registration of securities under the Securities Act of 1933 (Amendment)
Virpax Pharmaceuticals | 8-K: VIRPAX PHARMACEUTICALS REPORTS 2024 FIRST QUARTER RESULTS AND RECENT DEVELOPMENTS
Virpax Pharmaceuticals | 10-Q: Quarterly report
Virpax Pharmaceuticals | CORRESP: CORRESP
Virpax Pharmaceuticals | CORRESP: CORRESP
Virpax Pharmaceuticals | CORRESP: CORRESP
Virpax Pharmaceuticals | 8-K: Current report
Virpax Pharmaceuticals | CORRESP: CORRESP
Virpax Pharmaceuticals | S-1/A: General form for registration of securities under the Securities Act of 1933 (Amendment)
Virpax Pharmaceuticals | 8-K: Current report
Virpax Pharmaceuticals | S-1/A: General form for registration of securities under the Securities Act of 1933 (Amendment)
Virpax Pharmaceuticals | UPLOAD: Others
Virpax Pharmaceuticals | S-1: General form for registration of securities under the Securities Act of 1933
No Data